Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Cash Flows From Operating Activities:
Net income (loss)	$ 291,190	$ 256,513	$ (312,321)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	152,620	148,660	150,546
Amortization of debt issuance costs and discounts	6,234	6,419	5,025
Loss on early extinguishment of debt and write-off of discounts and debt issuance costs		52,011
Deferred income tax provision (benefit)	95,487	(4,117)	(31,414)
Equity-based compensation	18,158	39,722	7,467
Other including loss on impairment or disposal of assets, net	15,280	5,816	6,046
Changes in assets and liabilities:
Accounts receivable	10,334	(58,927)	24,761
Inventories	(27,112)	644	2,267
Prepaid expenses and other current assets	(7,020)	(2,424)	5,210
Accounts payable and accrued expenses	7,849	20,050	1,640
Accrued salaries, wages and benefits	(4,733)	11,375	(4,718)
Deferred revenue	329	33,070	25,065
Other accrued liabilities	1,961	(3,785)	(422)
Right-of-use assets and operating lease liabilities	580	396	561
Other assets and liabilities	3,431	(2,411)	(442)
Net cash provided by (used in) operating activities	564,588	503,012	(120,729)
Cash Flows From Investing Activities:
Capital expenditures	(200,705)	(128,854)	(109,175)
Net cash used in investing activities	(200,705)	(128,854)	(109,175)
Cash Flows From Financing Activities:
Proceeds from the issuance of debt, net		1,922,222	713,658
Repayments of long-term debt	(12,000)	(2,032,728)	(15,505)
Proceeds from draw on revolving credit facility			272,500
Repayments of revolving credit facility			(322,500)
Purchase of treasury stock	(693,623)	(215,749)	(12,406)
Payment of tax withholdings on equity-based compensation through shares withheld	(22,501)	(14,506)	(3,915)
Exercise of stock options	3,028	5,907	2,920
Debt issuance costs	(469)	(23,272)	(7,530)
Other financing activities	(484)	(6,771)	(3,018)
Net cash (used in) provided by financing activities	(726,049)	(364,897)	624,204
Change in Cash and Cash Equivalents, including Restricted Cash	(362,166)	9,261	394,300
Cash and Cash Equivalents, including Restricted Cash—Beginning of year	444,486	435,225	40,925
Cash and Cash Equivalents, including Restricted Cash—End of year	82,320	444,486	435,225
Supplemental Disclosures of Noncash Financing Activities
Capital expenditures in accounts payable and accrued expenses	$ 40,729	20,468	12,544
Other financing arrangements		$ 4,239	$ 3,890